Doximity Inc. reported its third-quarter fiscal 2025 earnings, surpassing analysts' expectations with an adjusted earnings per share (EPS) of $0.45, compared to the consensus estimate of $0.34. The company's revenue for the quarter reached $168.6 million, exceeding the expected $152.8 million and marking a 25% increase year-over-year from $135.3 million. Doximity also provided guidance for the fourth quarter, forecasting revenue between $132.5 million and $133.5 million, against the consensus of $123.8 million, and adjusted EBITDA between $62.5 million and $63.5 million. For the full fiscal year 2025, the company raised its revenue guidance to a range of $564.6 million to $565.6 million, up from the previously anticipated $535 million to $540 million, with adjusted EBITDA expected to be 47% of revenue. The company reported a diluted net income per share of $0.37 for the third quarter, up from $0.24 the previous year, and a net income of $75.2 million. Doximity highlighted the growth of its AI tools, which increased by 60% over the prior quarter, and noted over 610,000 unique providers using its clinical workflow tools. Following the earnings release, Doximity's stock surged by 21% after hours.